Itopride
- Generic Name
- Itopride
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C20H26N2O4
- CAS Number
- 122898-67-3
- Unique Ingredient Identifier
- 81BMQ80QRL
- Background
Itopride is a dopamine D2 antagonist with acetylcholinesterase inhibitory actions.
- Indication
Investigated for use/treatment in gastrointestinal diseases and disorders (miscellaneous).
- Associated Conditions
- Abdominal Pain, Anorexia, Dyspepsia, Functional Dyspepsia, Gastroenteritis, Nausea, Nausea and vomiting, Vomiting, Abdominal bloating, Pyrosis, Stomach discomfort
- Associated Therapies
- -
Potential Benefits of Itopride in the Management of Patients With Metabolic Associated Fatty Liver Disease (MAFLD)
- Conditions
- Interventions
- First Posted Date
- 2023-07-28
- Last Posted Date
- 2023-10-31
- Lead Sponsor
- October 6 University
- Target Recruit Count
- 60
- Registration Number
- NCT05966025
- Locations
- 🇪🇬
Maha Youssif Fekry, Giza, Egypt
Efficacy of Linaclotide in Patients With Overlapping Functional Gastrointestinal Disorders
- First Posted Date
- 2021-11-26
- Last Posted Date
- 2021-12-13
- Lead Sponsor
- RenJi Hospital
- Target Recruit Count
- 78
- Registration Number
- NCT05134584
- Locations
- 🇨🇳
RenJiH, Shanghai, Shanghai, China
Helicobacter Pylori Eradication in Functional Dyspepsia
- Conditions
- Interventions
- First Posted Date
- 2021-01-06
- Last Posted Date
- 2021-01-14
- Lead Sponsor
- Sir Ganga Ram Hospital
- Target Recruit Count
- 202
- Registration Number
- NCT04697641
- Locations
- 🇮🇳
Department of Gastroenterology & Hepatology, Sir Ganga Ram Hospital, New Delhi, India
Functional Dyspepsia: Validation of a Questionnaire for Symptom Assessment in FD PDS Subgroup
- Conditions
- Interventions
- First Posted Date
- 2020-12-01
- Last Posted Date
- 2020-12-01
- Lead Sponsor
- Universitaire Ziekenhuizen KU Leuven
- Target Recruit Count
- 100
- Registration Number
- NCT04647955
Functional Dyspepsia: Validation of the Leuven Postprandial Distress Scale (LPDS) in a Placebo-controlled Trial
- First Posted Date
- 2020-07-09
- Last Posted Date
- 2020-07-09
- Lead Sponsor
- Universitaire Ziekenhuizen KU Leuven
- Target Recruit Count
- 105
- Registration Number
- NCT04464369
- Locations
- 🇧🇪
University Hospitals Leuven, Leuven, Vlaams-Brabant, Belgium
Norfloxacin With Itopride Versus Norfloxacin in Secondary Prophylaxis of Spontaneous Bacterial Peritonitis
- Conditions
- Interventions
- First Posted Date
- 2019-11-13
- Last Posted Date
- 2019-11-13
- Lead Sponsor
- Tanta University
- Target Recruit Count
- 80
- Registration Number
- NCT04161768
- Locations
- 🇪🇬
Sherief Abd-Elsalam, Tanta, Egypt
Effectiveness of Prokinetic Agents in Improving Abdominal Discomfort at Colonoscopy
- First Posted Date
- 2019-09-26
- Last Posted Date
- 2021-09-02
- Lead Sponsor
- Mahidol University
- Target Recruit Count
- 525
- Registration Number
- NCT04104867
- Locations
- 🇹🇭
Chairat Supsamutchai, Bangkok, Bankok, Thailand
Itopride in Feeding Intolerance of Critically-ill Patients Receiving Enteral Nutrition
- First Posted Date
- 2018-10-05
- Last Posted Date
- 2018-10-05
- Lead Sponsor
- Ain Shams University
- Target Recruit Count
- 60
- Registration Number
- NCT03698292
- Locations
- 🇪🇬
Kasr Al Ainy Hospital, Cairo, Egypt
Efficacy of Prokinetics With Split Dose of PEG in Morning Colonoscopic Bowel Preparation
- First Posted Date
- 2012-01-20
- Last Posted Date
- 2012-04-03
- Lead Sponsor
- Inje University
- Target Recruit Count
- 152
- Registration Number
- NCT01513096
- Locations
- 🇰🇷
Haeundae Paik Hospital, Inje University School of Medicine, Busan, Korea, Republic of
Randomized Controlled Trial of Acupuncture for Functional Dyspepsia
- First Posted Date
- 2008-01-24
- Last Posted Date
- 2011-11-09
- Target Recruit Count
- 720
- Registration Number
- NCT00599677
- Locations
- 🇨🇳
Chengdu University of TCM, Chengdu, Sichuan, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.